Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 874021, 18 pages
http://dx.doi.org/10.1155/2014/874021
Review Article

Parasitic Pneumonia and Lung Involvement

110th Zonal Tuberculosis and Chest Disease Center, Chiang Mai, Thailand
210th Office of Disease Prevention and Control, Department of Disease Control, Ministry of Public Health, Chiang Mai 50100, Thailand
3Department of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand

Received 16 February 2014; Revised 15 May 2014; Accepted 20 May 2014; Published 9 June 2014

Academic Editor: Lisa M. Harrison

Copyright © 2014 Attapon Cheepsattayakorn and Ruangrong Cheepsattayakorn. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. K. Vijayan, “Tropical parasitic lung diseases,” The Indian Journal of Chest Diseases & Allied Sciences, vol. 50, no. 1, pp. 49–66, 2008. View at Google Scholar · View at Scopus
  2. S. L. Berk and A. Verghese, “Parasitic pneumonia,” Seminars in Respiratory Infections, vol. 3, no. 2, pp. 172–178, 1988. View at Google Scholar · View at Scopus
  3. W. Loffler, “Zur differential-diagnose der lungeninfiltrieurgen: 11 Uber fluchtige succedan-infiltrate (mit eosinophile),” Beitr Klin Erforsch Tuberk Lungenkr, vol. 79, pp. 368–392, 1992. View at Google Scholar
  4. V. K. Vijayan, “How to diagnose and manage common parasitic pneumonias,” Current Opinion in Pulmonary Medicine, vol. 13, no. 3, pp. 218–224, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. A. M. Dondorp, V. Desakorn, W. Pongtavornpinyo et al., “Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2,” PLoS Medicine, vol. 2, no. 8, Article ID e204, 2005. View at Publisher · View at Google Scholar
  6. Medicines for Malaria Venture, “The lifecycle of the malaria parasite,” http://www.mmv.org.
  7. United States Centers for Disease Control and Prevention, http://www.cdc.gov/malaria/about/disease.html.
  8. A. H. Fairlamb, “Future prospects for the chemotherapy of human trypanosomiasis. 1. Novel approaches to the chemotherapy of trypanosomiasis,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 84, no. 5, pp. 613–617, 1990. View at Publisher · View at Google Scholar · View at Scopus
  9. G. P. Maguire, T. Handojo, M. C. F. Pain et al., “Lung injury in uncomplicated and severe falciparum malaria: a longitudinal study in Papua, Indonesia,” Journal of Infectious Diseases, vol. 192, no. 11, pp. 1966–1974, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. M. D. Jamil, G. Kar, S. K. Biswas, and P. Kaushik, “Clinical manifestations of falciparum malaria in relation to parasitemia level in Southern Assam,” Journal of the Medical Association of India, vol. 57, 4 pages, 2009. View at Google Scholar
  11. S. Mharakurwa, C. Simoloka, P. E. Thuma, C. J. Shiff, and D. J. Sullivan, “PCR detection of Plasmodium falciparum in human urine and saliva samples,” Malaria Journal, vol. 5, article 103, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Sanklecha, N. Mehta, and H. Bagban, “Varied presentation of complicated falciparum malaria in a family,” Indian Pediatrics, vol. 49, no. 5, pp. 413–414, 2012. View at Google Scholar · View at Scopus
  13. P. H. O. Cabral, S. D. Andrade, W. D. Alecrim, M. G. C. Alecrim, and M. V. G. Lacerda, “Malaria and sickle cell anemia: report of complications and clinical management of three patients in a highly endemic area FOR Plasmodium vivax malaria in the Brazilian Amazon,” Case Reports and Clinical Practice Review, vol. 7, pp. 220–223, 2006. View at Google Scholar · View at Scopus
  14. J. D. Maguire, M. E. Fenton, A. I. Susanti, and J. B. Walker, “Plasmodium vivax-associated acute respiratory distress syndrome after extended travel in Afghanistan,” Travel Medicine and Infectious Disease, vol. 5, no. 5, pp. 301–305, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Sarkar, K. Saha, and C. S. Das, “Three cases of ARDS: an emerging complication of Plasmodium vivax malaria,” Lung India, vol. 27, no. 3, pp. 154–157, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Charoenpan, S. Indraprasit, S. Kiatboonsri, O. Suvachittanont, and S. Tanomsup, “Pulmonary edema in severe falciparum malaria. Hemodynamic study and clinicophysiologic correlation,” Chest, vol. 97, no. 5, pp. 1190–1197, 1990. View at Google Scholar · View at Scopus
  17. E. Pongponratn, M. Riganti, B. Punpoowong, and M. Aikawa, “Microvascular sequestration of parasitized erythrocytes in human falciparum malaria: a pathological study,” The American Journal of Tropical Medicine and Hygiene, vol. 44, no. 2, pp. 168–175, 1991. View at Google Scholar · View at Scopus
  18. N. Lacerda-Queiroz, M. A. Rachid, M. M. Teixeira, and A. L. Teixeira, “The role of platelet-activating factor receptor (PAFR) in lung pathology during experimental malaria,” International Journal for Parasitology, vol. 43, no. 1, pp. 11–15, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Autino, Y. Corbett, F. Castelli, and D. Taramelli, “Pathogenesis of malaria in tissues and blood,” Mediterranean Journal of Hematology and Infectious Diseases, vol. 4, no. 1, Article ID e2012061, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Djimdé, O. K. Doumbo, J. F. Cortese et al., “A molecular marker for chloroquine-resistant falciparum malaria,” The New England Journal of Medicine, vol. 344, no. 4, pp. 257–263, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. M. K. Laufer, P. C. Thesing, N. D. Eddington et al., “Return of chloroquine antimalarial efficacy in Malawi,” The New England Journal of Medicine, vol. 355, no. 19, pp. 1959–1966, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. T. K. Mutabingwa, “Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy!,” Acta Tropica, vol. 95, no. 3, pp. 305–315, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. World Health Organization, Guidelines for the Treatment of Malaria, World Health Organization, Geneva, Switzerland, 2006.
  24. World Health Organization, Management of Severe Malaria: A Practical Handbook, WHO, 3rd edition, 2012, http://www.who.int/malaria.
  25. K. M. Kiang, P. A. Bryant, D. Shingadia, S. Ladhani, A. C. Steer, and B. David, “The treatment of imported malaria in children: an update,” Archives of Disease in Childhood: Education and Practice Edition, vol. 98, no. 1, pp. 7–15, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. B. M. Greenwood, K. Bojang, C. J. M. Whitty, and G. A. T. Targett, “Malaria,” The Lancet, vol. 365, no. 9469, pp. 1487–1498, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. United States Centers for Disease Control and Prevention, “Amebiasis—biology,” http://www.cdc.gov/parasites/amebiasis/biology.html.
  28. J. P. Ackers and D. Mirelman, “Progress in research on Entamoeba histolytica pathogenesis,” Current Opinion in Microbiology, vol. 9, no. 4, pp. 367–373, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. S. M. Shamsuzzaman and Y. Hashiguchi, “Thoracic amebiasis,” Clinics in Chest Medicine, vol. 23, no. 2, pp. 479–492, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. S. N. Moonah, N. M. Jiang, and W. A. Petri Jr., “Host immune response to intestinal amebiasis,” PLoS Pathogens, vol. 9, no. 8, Article ID e1003489, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. Z. Hamzah, S. Petmitr, M. Mungthin, S. Leelayoova, and P. Chavalitshewinkoon-Petmitr, “Differential detection of Entamoeba histolytica, Entamoeba dispar, and Entamoeba moshkovskii by a single-round PCR assay,” Journal of Clinical Microbiology, vol. 44, no. 9, pp. 3196–3200, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Haque and W. A. Petri Jr., “Diagnosis of amebiasis in Bangladesh,” Archives of Medical Research, vol. 37, no. 2, pp. 273–276, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Tanyuksel and W. A. Petri Jr., “Laboratory diagnosis of amebiasis,” Clinical Microbiology Reviews, vol. 16, no. 4, pp. 713–729, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. I. Garcia-Rubio, C. Martinez-Cocera, S. Santos Magadan, B. Rodriguez-Jimenez, and S. asquez-cortes, “Hypersensitivity reactions to metronidazole,” Allergologica et Immunopathologica, vol. 34, no. 2, pp. 70–72, 2006. View at Google Scholar
  35. N. León-Sicairos, M. Reyes-López, C. Ordaz-Pichardo, and M. de la Garza, “Microbicidal action of lactoferrin and lactoferricin and their synergistic effect with metronidazole in Entamoeba histolytica,” Biochemistry and Cell Biology, vol. 84, no. 3, pp. 327–336, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Lotter and E. Tannich, “The current status of an amebiasis vaccine,” Archives of Medical Research, vol. 37, no. 2, pp. 292–296, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Basu, S. Roy, and P. Walden, “HLA class I-restricted T cell epitopes of the kinetoplastid membrane protein-11 presented by Leishmania donovani-infected human macrophages,” Journal of Infectious Diseases, vol. 195, no. 9, pp. 1373–1380, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. T. V. Piscopo and A. C. Mallia, “Leishmaniasis,” Postgraduate Medical Journal, vol. 82, no. 972, pp. 649–657, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. R. Russo, F. Laguna, R. López-Vélez et al., “Visceral leishmaniasis in those infected with HIV: clinical aspects and other opportunistic infections,” Annals of Tropical Medicine and Parasitology, vol. 97, supplement 1, pp. S99–S105, 2003. View at Google Scholar · View at Scopus
  40. A. A. Benzie, R. D. Goldin, and J. Walsh, “A case report of seronegative pulmonary leishmaniasis in an HIV-hepatitis C co-infected patient,” HIV Medicine, vol. 7, supplement 1, 36 pages, 2006, abstract no. P100. View at Google Scholar
  41. J. Alvar, P. Aparicio, A. Aseffa et al., “The relationship between leishmaniasis and AIDS: the second 10 years,” Clinical Microbiology Reviews, vol. 21, no. 2, pp. 334–359, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. V. Barreto-de-Souza, G. J. Pacheco, A. R. Silva et al., “Increased Leishmania replication in HIV-1-infected macrophages is mediated by tat protein through cyclooxygenase-2 expression and prostaglandin E 2 synthesis,” Journal of Infectious Diseases, vol. 194, no. 6, pp. 846–854, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. G. F. Cota, M. R. de Sousa, and A. Rabello, “Predictors of visceral leishmaniasis relapse in hiv-infected patients: a systematic review,” PLoS Neglected Tropical Diseases, vol. 5, no. 6, Article ID e1153, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. J. R. Santos-Oliveira, C. B. W. Giacoia-Gripp, P. de Oliveira et al., “High levels of T lymphocyte activation in Leishmania-HIV-1 co-infected individuals despite low HIV viral load,” BMC Infectious Diseases, vol. 10, pp. 358–363, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. P. Alexandrino-de-Oliveira, J. R. Santos-Oliveira, M. E. C. Dorval et al., “HIV/AIDS-associated visceral leishmaniasis in patients from an endemic area in Central-west Brazil,” Memorias do Instituto Oswaldo Cruz, vol. 105, no. 5, pp. 692–697, 2010. View at Google Scholar · View at Scopus
  46. P. Morales, J. J. Torres, M. Salavert, J. Pemán, J. Lacruz, and A. Solé, “Visceral leishmaniasis in lung transplantation,” Transplantation Proceedings, vol. 35, no. 5, pp. 2001–2003, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. J. R. Santos-Oliveira and A. M. Da-Cruz, “Lipopolysaccharide-induced cellular activation may participate in the immunopathogenesis of visceral leishmaniasis alone or in HIV coinfection,” International Journal of Microbiology, vol. 2012, Article ID 364534, 4 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. S. L. Croft and J. Engel, “Miltefosine—discovery of the antileishmanial activity of phospholipid derivatives,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 100, supplement 1, pp. 54–58, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. R. Sachdeva, A. C. Banerjea, N. Malla, and M. L. Dubey, “Immunogenicity and efficacy of single antigen Gp63, polytope and polytopeHSP70 DNA vaccines against visceral leishmaniasis in experimental mouse model,” PLoS ONE, vol. 4, no. 12, Article ID e7880, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. B. Bouteille and A. Buguet, “The detection and treatment of human African trypanosomiasis,” Research and Reports in Tropical Medicine, vol. 3, pp. 35–45, 2012. View at Google Scholar
  51. M. Ayub, S. A. Shah SA, M. Irfan, J. A. Khan, and S. N. Hashmi, “A case of human African trypanosomiasis during United Nation Mission in Liberia,” Pakistan Armed Forces Medical Journal, vol. 8, no. 1, 2011, http://www.pafmj.org/showdetails.php?id=187&t=c. View at Google Scholar
  52. V. G. Melnikov, F. F. Velasco, F. E. Gómez, F. G. Rodríguez, and O. R. Dobrovinskaya, “Pathologic changes in lungs caused by Mexican isolates of Trypanosoma cruzi in the acute phase of infection in mice,” The American Journal of Tropical Medicine and Hygiene, vol. 73, no. 2, pp. 301–306, 2005. View at Google Scholar · View at Scopus
  53. M. S. Šíma, H. Havelková, L. Quan et al., “Genetic control of resistance to Trypanosoma brucei infection in mice,” PLoS Neglected Tropical Diseases, vol. 5, no. 6, Article ID e1173, 2011. View at Google Scholar
  54. D. Biswas, A. Choudhury, and K. K. Misra, “Histopathology of Trypanosoma (Trypanozoon) evansi infection in bandicoot rat. I. Visceral organs,” Experimental Parasitology, vol. 99, no. 3, pp. 148–159, 2001. View at Publisher · View at Google Scholar · View at Scopus
  55. M. D. C. Pereira Nuñes, M. de Melo Barbosa, V. A. Andrade Brum, and M. O. da Costa Rocha, “Morphofunctional characteristics of the right ventricle in Chagas' dilated cardiomyopathy,” International Journal of Cardiology, vol. 94, no. 1, pp. 79–85, 2004. View at Publisher · View at Google Scholar · View at Scopus
  56. J. Pépin, N. Khonde, F. Maiso et al., “Short-course eflornithine in Gambian trypanosomiasis: a multicentre randomized controlled trial,” Bulletin of the World Health Organization, vol. 78, no. 11, pp. 1284–1295, 2000. View at Google Scholar · View at Scopus
  57. F. W. Jennings, “Future prospects for the chemotherapy of human trypanosomiasis. 2. Combination chemotherapy and African trypanosomiasis,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 84, no. 5, pp. 618–621, 1990. View at Publisher · View at Google Scholar · View at Scopus
  58. C. N. Paiva, D. F. Feijó, F. F. Dutra et al., “Oxidative stress fuels Trypanosoma cruzi infection in mice,” The Journal of Clinical Investigation, vol. 122, no. 7, pp. 2531–2542, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. G. J. Feldman and H. W. Parker, “Visceral larva migrans associated with the hypereosinophilic syndrome and the onset of severe asthma,” Annals of Internal Medicine, vol. 116, no. 10, pp. 838–840, 1992. View at Google Scholar · View at Scopus
  60. J. Roig, J. Romeu, C. Riera, A. Texido, C. Domingo, and J. Morera, “Acute eosinophilic pneumonia due to toxocariasis with bronchoalveolar lavage findings,” Chest, vol. 102, no. 1, pp. 294–296, 1992. View at Google Scholar · View at Scopus
  61. A. K. M. Bartelink, L. M. Kortbeek, H. J. Huidekoper, J. Meulenbelt, and F. van Knapen, “Acute respiratory failure due to toxocara infection,” The Lancet, vol. 342, no. 8881, p. 1234, 1993. View at Google Scholar · View at Scopus
  62. J. F. Magnaval, L. T. Glickman, P. Dorchies, and B. Morassin, “Highlights of human toxocariasis,” Korean Journal of Parasitology, vol. 39, no. 1, pp. 1–11, 2001. View at Google Scholar · View at Scopus
  63. L. T. Glickman, J.-F. Magnaval, L. M. Domanski et al., “Visceral larva migrans in French adults: a new disease syndrome?” The American Journal of Epidemiology, vol. 125, no. 6, pp. 1019–1034, 1987. View at Google Scholar · View at Scopus
  64. D. Nathwani, R. B. S. Laing, and P. F. Currie, “Covert toxocariasis—a cause of recurrent abdominal pain in childhood,” British Journal of Clinical Practice, vol. 46, no. 4, p. 271, 1992. View at Google Scholar · View at Scopus
  65. J.-F. Magnaval, R. Fabre, P. Maurieres, J.-P. Charlet, and B. de Larrard, “Evaluation of an immunoenzymatic assay detecting specific anti-Toxocara immunoglobulin E for diagnosis and posttreatment follow-up of human toxocariasis,” Journal of Clinical Microbiology, vol. 30, no. 9, pp. 2269–2274, 1992. View at Google Scholar · View at Scopus
  66. J.-F. Magnaval, R. Fabre, P. Maurieres, J.-P. Charlet, and B. de Larrard, “Application of the Western blotting procedure for the immunodiagnosis of human toxocariasis,” Parasitology Research, vol. 77, no. 8, pp. 697–702, 1991. View at Google Scholar · View at Scopus
  67. L. N. Rasmussen, M. Dirdal, and N. H. Birkebaek, “‘Covert toxocariasis’ in a child treated with low-dose diethylcarbamazine,” Acta Paediatrica, International Journal of Paediatrics, vol. 82, no. 1, pp. 116–118, 1993. View at Google Scholar · View at Scopus
  68. J.-F. Magnaval, “Comparative efficacy of diethylcarbamazine and mebendazole for the treatment of human toxocariasis,” Parasitology, vol. 110, part 5, pp. 529–533, 1995. View at Google Scholar · View at Scopus
  69. D. Sturchler, P. Schubarth, M. Gualzata, B. Gottstein, and A. Oettli, “Thiabendazole vs. albendazole in treatment of toxocariasis: a clinical trial,” Annals of Tropical Medicine and Parasitology, vol. 83, no. 5, pp. 473–478, 1989. View at Google Scholar · View at Scopus
  70. E. M. Dodds, “Toxoplasmosis,” Current Opinion in Ophthalmology, vol. 17, no. 6, pp. 557–561, 2006. View at Publisher · View at Google Scholar · View at Scopus
  71. E. Monsó, R. Vidal, X. de Gracia, and A. Moragas, “Pulmonary toxoplasmoma presenting as obstructive pneumonia,” Thorax, vol. 41, no. 6, pp. 489–490, 1986. View at Google Scholar · View at Scopus
  72. G. Nash, R. L. Kerschmann, B. Herndier, and J. P. Dubey, “The pathological manifestations of pulmonary toxoplasmosis in the acquired immunodeficiency syndrome,” Human Pathology, vol. 25, no. 7, pp. 652–658, 1994. View at Publisher · View at Google Scholar · View at Scopus
  73. S. Laibe, S. Ranque, C. Curtillet, F. Faraut, H. Dumon, and J. Franck, “Timely diagnosis of disseminated toxoplasmosis by sputum examination,” Journal of Clinical Microbiology, vol. 44, no. 2, pp. 646–648, 2006. View at Publisher · View at Google Scholar · View at Scopus
  74. E. Petersen, B. Edvinsson, B. Lundgren, T. Benfield, and B. Evengård, “Diagnosis of pulmonary infection with Toxoplasma gondii in immunocompromised HIV-positive patients by real-time PCR,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 25, no. 6, pp. 401–404, 2006. View at Publisher · View at Google Scholar · View at Scopus
  75. P. J. Krause, “Babesiosis,” Medical Clinics of North America, vol. 86, no. 2, pp. 361–373, 2002. View at Publisher · View at Google Scholar · View at Scopus
  76. S. J. Swanson, D. Neitzel, K. D. Reed, and E. A. Belongia, “Coinfections acquired from Ixodes ticks,” Clinical Microbiology Reviews, vol. 19, no. 4, pp. 708–727, 2006. View at Publisher · View at Google Scholar · View at Scopus
  77. M. R. Boustani, T. J. Lepore, J. A. Gelfand, and D. S. Lazarus, “Acute respiratory failure in patients treated for babesiosis,” The American Journal of Respiratory and Critical Care Medicine, vol. 149, no. 6, pp. 1689–1691, 1994. View at Google Scholar · View at Scopus
  78. M. L. Horowitz, F. Coletta, and A. M. Fein, “Delayed onset adult respiratory distress syndrome in babesiosis,” Chest, vol. 106, no. 4, pp. 1299–1301, 1994. View at Google Scholar · View at Scopus
  79. P. J. Krause, “Babesiosis diagnosis and treatment,” Vector Borne and Zoonotic Diseases, vol. 3, no. 1, pp. 45–51, 2003. View at Google Scholar · View at Scopus
  80. M. Raju, J. C. Salazar, H. Leopold, and P. J. Krause, “Atovaquone and azithromycin treatment for babesiosis in an infant,” Pediatric Infectious Disease Journal, vol. 26, no. 2, pp. 181–183, 2007. View at Publisher · View at Google Scholar · View at Scopus
  81. V. K. Vijayan, “Tropical pulmonary eosinophilia: pathogenesis, diagnosis and management,” Current Opinion in Pulmonary Medicine, vol. 13, no. 5, pp. 428–433, 2007. View at Publisher · View at Google Scholar · View at Scopus
  82. E. A. Ottesen, “Immunological aspects of lymphatic filariasis and onchocerciasis in man,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 78, pp. 9–18, 1984. View at Google Scholar · View at Scopus
  83. C. Frimodt-Möller and R. M. Barton, “A pseudo-tuberculosis condition associated with eosinophilia,” Indian Medical Gazette, vol. 75, no. 10, pp. 607–613, 1940. View at Google Scholar
  84. R. J. Weingarten, “Tropical eosinophilia,” The Lancet, vol. 241, no. 6230, pp. 103–105, 1943. View at Google Scholar · View at Scopus
  85. S. R. Kamat, B. D. Pimparkar, S. D. Store, N. V. Warrier, and Y. C. Fakey, “Study of clinical, radiological and pulmonary function patterns of response to treatment in pulmonary eosinophilia,” The Indian Journal of Chest Diseases, vol. 12, no. 3, pp. 91–100, 1970. View at Google Scholar · View at Scopus
  86. S. P. Basu, “X-ray appearance in lung fields in tropical eosinophilia,” Indian Medical Gazette, vol. 89, pp. 212–217, 1954. View at Google Scholar
  87. N. Islam and K. S. Huque, “Radiological features of tropical eosinophilia,” Journal of Tropical Medicine and Hygiene, vol. 68, pp. 117–180, 1965. View at Google Scholar
  88. F. Y. Khoo and T. J. Danaraj, “The roentgenographic appearance of eosinophilic lung (tropical eosinophilia),” The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine, vol. 83, pp. 251–259, 1960. View at Google Scholar · View at Scopus
  89. World Health Organization, Division of Control of Tropical Diseases, Lymphatic Filariasis Infection and Disease: Control Strategies, (TDR/CTD/FIL/Penang), 1994.
  90. M. Sandhu, S. Mukhopadhyay, and S. K. Sharma, “Tropical pulmonary eosinophilia: a comparative evaluation of plain chest radiography and computed tomography,” Australasian Radiology, vol. 40, no. 1, pp. 32–37, 1996. View at Google Scholar · View at Scopus
  91. S. Johnson, R. Wilkinson, and R. N. Davidson, “Tropical respiratory medicine. 4. Acute tropical infections and the lung,” Thorax, vol. 49, no. 7, pp. 714–718, 1994. View at Google Scholar · View at Scopus
  92. E. A. Ottesen and T. B. Nutman, “Tropical pulmonary eosinophilia,” Annual Review of Medicine, vol. 43, pp. 417–424, 1992. View at Google Scholar · View at Scopus
  93. T. J. Danaraj and J. F. Schacher, “I/D test with Dirofilaria immitis extract in eosinophilic lung (tropical eosinophilia),” The American Journal of Tropical Medicine and Hygiene, vol. 8, no. 6, pp. 640–643, 1959. View at Google Scholar
  94. J. K. G. Webb, C. K. Job, and E. W. Gault, “Tropical eosinophilia: demonstration of microfilariae in lung, liver and lymph nodes,” The Lancet, vol. 275, no. 7129, pp. 835–842, 1960. View at Google Scholar · View at Scopus
  95. V. V. Joshi, F. E. Udwadia, and R. K. Gadgil, “Etiology of tropical eosinophilia. A study of lung biopsies and review of published reports,” The American Journal of Tropical Medicine and Hygiene, vol. 18, no. 2, pp. 231–240, 1969. View at Google Scholar · View at Scopus
  96. T. J. Danaraj, G. Pacheco, K. Shanmugaratnam, and P. C. Beaver, “The etiology and pathology of eosinophilic lung (tropical eosinophilia),” The American Journal of Tropical Medicine and Hygiene, vol. 15, no. 2, pp. 183–189, 1966. View at Google Scholar · View at Scopus
  97. E. A. Ottesen, F. A. Neva, R. S. Paranjape, S. P. Tripathy, K. V. Thiruvengadam, and M. A. Beaver, “Specific allergic sensitization to filarial antigens in tropical pulmonary eosinophilia,” The Lancet, vol. 314, no. 8153, pp. 1158–1161, 1979. View at Google Scholar
  98. R. Viswanathan, R. C. Bagai, and R. Saran, “Leukocyte adhesion phenomenon in pulmonary eosinophilia (tropical eosinophilia),” The American Review of Respiratory Disease, vol. 107, no. 2, pp. 298–300, 1973. View at Google Scholar · View at Scopus
  99. G. Dreyer, J. Noroes, A. Rocha, and D. Addiss, “Detection of living adult Wuchereria bancrofti in a patient with tropical pulmonary eosinophilia,” Brazilian Journal of Medical and Biological Research, vol. 29, no. 8, pp. 1005–1008, 1996. View at Google Scholar · View at Scopus
  100. C. S. Perera, L. M. Perera, C. de Silva, W. Abeywickreme, A. S. Dissanaike, and M. M. Ismail, “An eosinophilic granuloma containing an adult female Wuchereria bancrofti in a patient with tropical pulmonary eosinophilia,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 86, no. 5, p. 542, 1992. View at Publisher · View at Google Scholar · View at Scopus
  101. T. B. Nutman, V. K. Vijayan, P. Pinkston et al., “Tropical pulmonary eosinophilia: analysis of antifilarial antibody localized to the lung,” Journal of Infectious Diseases, vol. 160, no. 6, pp. 1042–1050, 1989. View at Google Scholar · View at Scopus
  102. V. K. Vijayan, Tropical eosinophilia: bronchoalveolar lavage and pulmonary pathophysiology in relation to treatment [Ph.D. thesis], University of Madras, Madras, India, 1988.
  103. V. K. Vijayan, K. V. Kuppu Rao, K. Sankaran, P. Venkatesan, and R. Prabhakar, “Tropical eosinophilia: clinical and physiological response to diethylcarbamazine,” Respiratory Medicine, vol. 85, no. 1, pp. 17–20, 1991. View at Google Scholar · View at Scopus
  104. World Health Organization, Final Report: Joint WPRO/SEARO Working Group on Brugian Filariasis, WHO, Manila, Philippines, 1979.
  105. R. D. Ganatra, U. K. Sheth, and R. A. Lewis, “Diethylcarbamazine (hetrazan) in tropical eosinophilia,” The Indian Journal of Medical Research, vol. 46, no. 2, pp. 205–222, 1958. View at Google Scholar · View at Scopus
  106. S. J. Baker, K. T. Rajan, and S. Devadatta, “Treatment of tropical eosinophilia: a controlled trial,” The Lancet, vol. 274, no. 7095, pp. 144–147, 1959. View at Google Scholar · View at Scopus
  107. F. Ciferri, “Human pulmonary dirofilariasis in the United States: a critical review,” The American Journal of Tropical Medicine and Hygiene, vol. 31, no. 2, pp. 302–308, 1982. View at Google Scholar · View at Scopus
  108. R. B. Adkins Jr. and A. H. Dao, “Pulmonary dirofilariasis: a diagnostic challenge,” Southern Medical Journal, vol. 77, no. 3, pp. 372–374, 1984. View at Google Scholar · View at Scopus
  109. P. J. Asimacopoulos, A. Katras, and B. Christie, “Pulmonary dirofilariasis; the largest single-hospital experience,” Chest, vol. 102, no. 3, pp. 851–855, 1992. View at Google Scholar · View at Scopus
  110. J. C. Darrow and E. E. Lack, “Solitary lung nodule due to dirofilaria immitis (dog “heartworm”),” Journal of Surgical Oncology, vol. 16, no. 3, pp. 219–224, 1981. View at Google Scholar · View at Scopus
  111. A. J. Larrieu, I. Wiener, L. G. Gomez, and E. H. Williams, “Human pulmonary dirofilariasis presenting as a solitary pulmonary nodule,” Chest, vol. 75, no. 4, pp. 511–512, 1979. View at Google Scholar · View at Scopus
  112. W. H. Risher, E. F. Crocker, E. N. Beckman, J. B. Blalock, and J. L. Ochsner, “Pulmonary dirofilariasis. The largest single-institution experience,” Journal of Thoracic and Cardiovascular Surgery, vol. 97, no. 2, pp. 303–308, 1989. View at Google Scholar · View at Scopus
  113. A. Biswas, P. Reilly, A. Perez IV, and M. H. Yassin, “Human pulmonary dirofilariasis presenting as a solitary pulmonarynodule: a case report and a brief review of literature,” Respiratory Medicine Case Report, vol. 10, pp. 40–42, 2013. View at Google Scholar
  114. O. Rena, M. Leutner, and C. Casadio, “Human pulmonary dirofilariasis: uncommon cause of pulmonary coin-lesion,” European Journal of Cardio-Thoracic Surgery, vol. 22, no. 1, pp. 157–159, 2002. View at Publisher · View at Google Scholar · View at Scopus
  115. R. C. Neafie, D. H. Conner, and W. M. Meyers, “Dirofilariasis,” in Pathology of Tropical and Extraordinary Diseases, C. H. Binford and D. H. Conner, Eds., pp. 391–396, Armed Forces Institute of Pathology, Washinton, DC, USA, 1976. View at Google Scholar
  116. F. Ciferri, “Human pulmonary dirofilariasis in the West,” Western Journal of Medicine, vol. 134, no. 2, pp. 158–162, 1981. View at Google Scholar · View at Scopus
  117. R. Rodrigues-Silva, H. Moura, G. Dreyer, and L. Rey, “Human pulmonary dirofilariasis: a review,” Revista do Instituto de Medicina Tropical de São Paulo, vol. 37, no. 6, pp. 523–530, 1995. View at Google Scholar · View at Scopus
  118. E. A. Mulanovich, V. E. Mulanovich, and K. V. I. Rolston, “A case of Dirofilaria pulmonary infection coexisting with lung cancer,” Journal of Infection, vol. 56, no. 4, pp. 241–243, 2008. View at Publisher · View at Google Scholar · View at Scopus
  119. S. Pampiglione, F. Rivasi, and S. Paolino, “Human pulmonary dirofilariasis,” Histopathology, vol. 29, no. 1, pp. 69–72, 1996. View at Google Scholar · View at Scopus
  120. S. Pampiglione, F. Rivasi, G. Angeli et al., “Dirofilariasis due to Dirofilaria repens in Italy, an emergent zoonosis: report of 60 new cases,” Histopathology, vol. 38, no. 4, pp. 344–354, 2001. View at Publisher · View at Google Scholar · View at Scopus
  121. M. de Campos Jr., C. S. V. Barbas, L. T. B. Filomeno et al., “Human pulmonary dirofilariasis: analysis of 24 cases from Sao Paulo, Brazil,” Chest, vol. 112, no. 3, pp. 729–733, 1997. View at Google Scholar · View at Scopus
  122. T. Miyoshi, H. Tsubouchi, A. Iwasaki, T. Shiraishi, K. Nabeshima, and T. Shirakusa, “Human pulmonary dirofilariasis: a case report and review of the recent Japanese literature,” Respirology, vol. 11, no. 3, pp. 343–347, 2006. View at Publisher · View at Google Scholar · View at Scopus
  123. L. T. Glickman, R. B. Grieve, and P. M. Schantz, “Serologic diagnosis of zoonotic pulmonary dirofilariasis,” The American Journal of Medicine, vol. 80, no. 2, pp. 161–164, 1986. View at Google Scholar · View at Scopus
  124. T. Yamashiro, A. Inoue, T. Tamiya, N. Suzuki, T. Moriki, and K. Araki, “The usefulness of immunologic methods for diagnosis and follow-up study of a case of pulmonary dirofilariasis,” Japanese Journal of Thoracic Diseases, vol. 27, no. 6, pp. 747–753, 1989. View at Google Scholar · View at Scopus
  125. N. Magono, H. Yosimatu, Y. Suzuki et al., “A case of pulmonary dirofilariasis diagnosed by biopsy, immunological tests and the clinical course without operation,” The Journal of Japanese Respiratory Society, vol. 47, no. 6, pp. 467–470, 2009. View at Google Scholar · View at Scopus
  126. A. Echeverri, R. F. Long, W. Check, and C. M. Burnett, “Pulmonary dirofilariasis,” Annals of Thoracic Surgery, vol. 67, no. 1, pp. 201–202, 1999. View at Publisher · View at Google Scholar · View at Scopus
  127. T. Jelinek, J. Schulte-Hillen, and T. Löscher, “Human dirofilariasis,” International Journal of Dermatology, vol. 35, no. 12, pp. 872–875, 1996. View at Google Scholar · View at Scopus
  128. C. L. Daley, “Pulmonary infections in the tropics: impact of HIV infection,” Thorax, vol. 49, no. 4, pp. 370–378, 1994. View at Google Scholar · View at Scopus
  129. R. M. Genta, “Global prevalence of strongyloidiasis: critical review with epidemiologic insights into the prevention of disseminated disease,” Reviews of Infectious Diseases, vol. 11, no. 5, pp. 755–767, 1989. View at Google Scholar · View at Scopus
  130. V. A. Neto, J. Pasternak, A. A. B. Moreira, M. I. S. Duarte, R. Campos, and L. M. A. Braz, “Strongyloides stercoralis hyperinfection in the acquired immunodeficiency syndrome,” The American Journal of Medicine, vol. 87, no. 5, pp. 602–603, 1989. View at Google Scholar · View at Scopus
  131. C. P. Conlon, A. J. Pinching, C. U. Perera, A. Moody, N. P. Luo, and S. B. Lucas, “HIV-related enteropathy in Zambia: a clinical, microbiological, and histological study,” The American Journal of Tropical Medicine and Hygiene, vol. 42, no. 1, pp. 83–88, 1990. View at Google Scholar · View at Scopus
  132. E. B. Scowden, W. Schaffner, and W. J. Stone, “Overwhelming strongyloidiasis. An unappreciated opportunistic infection,” Medicine, vol. 57, no. 6, pp. 527–544, 1978. View at Google Scholar · View at Scopus
  133. M. M. Gompels, J. Todd, B. S. Peters, J. Main, and A. J. Pinching, “Disseminated strongyloidiasis in AIDS: uncommon but important,” AIDS, vol. 5, no. 3, pp. 329–332, 1991. View at Google Scholar · View at Scopus
  134. O. Armignacco, A. Capecchi, P. de Mori, and L. R. Grillo, “Strongyloides stercoralis hyperinfection and the acquired immunodeficiency syndrome,” The American Journal of Medicine, vol. 86, no. 2, p. 258, 1989. View at Google Scholar · View at Scopus
  135. S. Maayan, G. P. Wormser, J. Widerhorn, E. R. Sy, Y. H. Kim, and J. A. Ernst, “Strongyloides stercoralis hyperinfection in a patient with the acquired immune deficiency syndrome,” The American Journal of Medicine, vol. 83, no. 5, pp. 945–948, 1987. View at Google Scholar · View at Scopus
  136. D. W. T. Crompton, “How much human helminthiasis is there in the world?” Journal of Parasitology, vol. 85, no. 3, pp. 397–403, 1999. View at Publisher · View at Google Scholar · View at Scopus
  137. W. Peng, X. Zhou, and R. B. Gasser, “Ascaris egg profiles in human faeces: biological and epidemiological implications,” Parasitology, vol. 127, part 3, pp. 283–290, 2003. View at Publisher · View at Google Scholar · View at Scopus
  138. M. Yazicioǧlu, Ü. Önş, and I. Yalçin, “Peripheral and nasal eosinophilia and serum total immunoglobulin e levels in children with ascariasis,” Turkish Journal of Pediatrics, vol. 38, no. 4, pp. 477–484, 1996. View at Google Scholar · View at Scopus
  139. A. Santra, T. Bhattacharya, A. Chowdhury et al., “Serodiagnosis of ascariasis with specific IgG4 antibody and its use in an epidemiological study,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 95, no. 3, pp. 289–292, 2001. View at Google Scholar · View at Scopus
  140. R. M. Ford, “Transient pulmonary eosinophilia and asthma: a review of 20 cases occurring in 5, 702 asthma sufferers,” The American Review of Respiratory Diseases, vol. 93, no. 5, pp. 797–803, 1996. View at Google Scholar
  141. L. X. Liu and P. F. Weller, “Strongyloidiasis and other intestinal nematode infections,” Infectious Disease Clinics of North America, vol. 7, no. 3, pp. 655–682, 1993. View at Google Scholar · View at Scopus
  142. L. A. Citro, M. E. Gordon, and W. T. Miller, “Eosinophilic lung disease (or how to slice P.I.E.),” The American Journal of Roentgenology, Radium Therapy and Nuclear Medicine, vol. 117, no. 4, pp. 787–797, 1973. View at Google Scholar · View at Scopus
  143. K. E. Hoagland and G. A. Schad, “Necator americanus and Ancylostoma duodenale: life history parameters and epidemiological implications of two sympatric hookworms of humans,” Experimental Parasitology, vol. 44, no. 1, pp. 36–49, 1978. View at Google Scholar · View at Scopus
  144. P. Hotez, “Human hookworm infection,” in Intestinal Helminths, M. J. G. Farthing, G. T. Keusch, and D. Wakelin, Eds., pp. 129–150, Chapman and Hall, London, UK, 1995. View at Google Scholar
  145. T. A. Nawalinski and G. A. Schad, “Arrested development in Ancylostoma duodenale: course of a self induced infection in man,” The American Journal of Tropical Medicine and Hygiene, vol. 23, no. 5, pp. 895–898, 1974. View at Google Scholar · View at Scopus
  146. M. Cappello, L. P. Clyne, P. McPhedran, and P. J. Hotez, “Ancylostoma factor Xa inhibitor: partial purification and its identification as a major hookworm-derived anticoagulant in vitro,” Journal of Infectious Diseases, vol. 167, no. 6, pp. 1474–1477, 1993. View at Google Scholar · View at Scopus
  147. F. Nakamura-Uchiyama, H. Mukae, and Y. Nawa, “Paragonimiasis: a Japanese perspective,” Clinics in Chest Medicine, vol. 23, no. 2, pp. 409–420, 2002. View at Publisher · View at Google Scholar · View at Scopus
  148. D. Blair, Z.-B. Xu, and T. Agatsuma, “Paragonimiasis and the genus Paragonimus,” Advances in Parasitology, vol. 42, pp. 113–222, 1999. View at Google Scholar · View at Scopus
  149. C. H. King, “Pulmonary flukes,” in Lung Biology in Health and Disease: Parasitic Lung Disease, A. A. F. Mahamoud, Ed., pp. 157–169, Marcel Dekker, New York, NY, USA, 1997. View at Google Scholar
  150. T. S. Singh, H. Sugiyama, and A. Rangsiruji, “Paragonimus & paragonimiasis in India,” Indian Journal of Medical Research, vol. 136, no. 2, pp. 192–204, 2012. View at Google Scholar · View at Scopus
  151. L. Hasdiraz, F. Oǧuzkaya, and M. Bilgin, “Is lobectomy necessary in the treatment of pulmonary hydatid cysts?” ANZ Journal of Surgery, vol. 76, no. 6, pp. 488–490, 2006. View at Publisher · View at Google Scholar · View at Scopus
  152. Z. B. Xu, “Studies on clinical manifestations, diagnosis and control of paragonimiasis in China,” Southeast Asian Journal of Tropical Medicine and Public Health, vol. 22, supplement 1, pp. 345–348, 1991. View at Google Scholar · View at Scopus
  153. I. P. Oloyede, G. B. Inah, D. E. Bassey, and E. E. Ekanem, “Comparative study of radiological findings in pulmonary tuberculosis and paragonimiasis in children in a Southern Nigeria fishing community,” West African Journal of Radiology, vol. 21, no. 1, pp. 17–20, 2014. View at Google Scholar
  154. H. Mukae, H. Taniguchi, N. Matsumoto et al., “Clinicoradiologic features of pleuropulmonary Paragonimus westermani on Kyusyu Island, Japan,” Chest, vol. 120, no. 2, pp. 514–520, 2001. View at Publisher · View at Google Scholar · View at Scopus
  155. R. Suwanik and C. Harinasuta, “Pulmonary paragonimiasis: an evaluation of roentgen findings in 38 positive sputum patients in an endemic area in Thailand,” The American Journal of Roentgenology, vol. 81, no. 2, pp. 236–244, 1959. View at Google Scholar
  156. K. Jeon, W. Koh, H. Kim et al., “Clinical features of recently diagnosed pulmonary paragonimiasis in Korea,” Chest, vol. 128, no. 3, pp. 1423–1430, 2005. View at Publisher · View at Google Scholar · View at Scopus
  157. T. N. Singh, S. Kananbala, and K. S. Devi, “Pleuropulmonary paragonimiasis mimicking pulmonary tuberculosis—a report of three cases,” Indian Journal of Medical Microbiology, vol. 23, no. 2, pp. 131–134, 2005. View at Google Scholar · View at Scopus
  158. J. Gómez-Seco, M. J. Rodríguez-Guzmán, M. J. Rodríguez-Nieto, P. F. Gómez-Escolar, T. Presa-Abos, and J. Fortes-Alen, “Pulmonary paragonimiasis,” Archivos de Bronconeumologia, vol. 47, no. 12, pp. 610–612, 2011. View at Publisher · View at Google Scholar · View at Scopus
  159. E. Schwartz, J. Rozenman, and M. Perelman, “Pulmonary manifestations of early schistosome infection among nonimmune travelers,” The American Journal of Medicine, vol. 109, no. 9, pp. 718–722, 2000. View at Publisher · View at Google Scholar · View at Scopus
  160. E. Lee, B. Na, Y. Bae et al., “Identification of immunodominant excretory-secretory cysteine proteases of adult Paragonimus westermani by proteome analysis,” Proteomics, vol. 6, no. 4, pp. 1290–1300, 2006. View at Publisher · View at Google Scholar · View at Scopus
  161. B. Na, S. Kim, E. Lee et al., “Critical roles for excretory-secretory cysteine proteases during tissue invasion of Paragonimus westermani newly excysted metacercariae,” Cellular Microbiology, vol. 8, no. 6, pp. 1034–1046, 2006. View at Publisher · View at Google Scholar · View at Scopus
  162. C. Wongkham, P. M. Intapan, W. Maleewong, and M. Miwa, “Evaluation of human IgG subclass antibodies in the serodiagnosis of paragonimiasis heterotremus,” Asian Pacific Journal of Allergy and Immunology, vol. 23, no. 4, pp. 205–211, 2005. View at Google Scholar · View at Scopus
  163. J. Song, G. Hong, J. U. Song et al., “A case of pleural paragonimiasis confused with tuberculous pleurisy,” Tuberculosis and Respiratory Diseases, vol. 76, no. 4, pp. 175–178, 2014. View at Google Scholar
  164. I. D. Vélez, J. E. Ortega, and L. E. Velásquez, “Paragonimiasis: a review from Columbia,” Clinics in Chest Medicine, vol. 23, no. 2, pp. 421–431, 2002. View at Google Scholar
  165. J. Keiser, D. Engels, G. Büscher, and J. Utzinger, “Triclabendazole for the treatment of fascioliasis and paragonimiasis,” Expert Opinion on Investigational Drugs, vol. 14, no. 12, pp. 1513–1526, 2005. View at Publisher · View at Google Scholar · View at Scopus
  166. E. Schwartz, “Pulmonary schistosomiasis,” Clinics in Chest Medicine, vol. 23, no. 2, pp. 433–443, 2002. View at Publisher · View at Google Scholar · View at Scopus
  167. F. Walt, “The Katayama syndrome,” South African Medical Journal, vol. 28, no. 5, pp. 89–93, 1954. View at Google Scholar · View at Scopus
  168. S. A. Baharoon, H. H. Al-Jahdali, H. S. Bamefleh, A. M. Elkeir, and N. M. Yamani, “Acute pulmonary schistosomiasis,” Journal of Global Infectious Diseases, vol. 3, no. 3, pp. 293–295, 2011. View at Google Scholar
  169. J. F. Doherty, A. H. Moody, and S. G. Wright, “Katayama fever: an acute manifestation of schistosomiasis,” British Medical Journal, vol. 313, no. 7064, pp. 1071–1072, 1996. View at Google Scholar · View at Scopus
  170. T. Niemann, H. P. Marti, S. H. Duhnsen, and G. Bongartz, “Pulmonary schistosomiasis-imaging features,” Journal of Radiology Case Reports, vol. 4, no. 9, pp. 37–43, 2010. View at Publisher · View at Google Scholar · View at Scopus
  171. L. Nguyen, J. Estrella, E. A. Jett, E. L. Grunvald, L. Nicholson, and D. L. Levin, “Acute schistosomiasis in nonimmune travelers: chest CT findings in 10 patients,” The American Journal of Roentgenology, vol. 186, no. 5, pp. 1300–1303, 2006. View at Publisher · View at Google Scholar · View at Scopus
  172. M. S. Lapa, E. V. Ferreira, C. Jardim, B. D. C. Martins, J. S. Arakaki, and R. Souza, “Clinical characteristics of pulmonary hypertension patients in two reference centers in the city of Sao Paulo,” Revista da Associacao Medica Brasileira, vol. 52, no. 3, pp. 139–143, 2006. View at Google Scholar
  173. W. Morris and C. M. Knauer, “Cardiopulmonary manifestations of schistosomiasis,” Seminars in Respiratory Infections, vol. 12, no. 2, pp. 159–170, 1997. View at Google Scholar · View at Scopus
  174. S. I. Sersar, R. A. Albumaaty, H. A. Elnahas et al., “A diagnostic dilemma of right lower lobe collapse caused by pulmonary bilharsiasis,” Heart Lung and Circulation, vol. 15, no. 1, pp. 50–52, 2006. View at Publisher · View at Google Scholar · View at Scopus
  175. G. Butrous, “Schistosomiasis pulmonary hypertension: the forgotten disease,” Egyptian Journal of Bronchology, vol. 2, no. 1, pp. 143–146, 2008. View at Google Scholar
  176. R. de Amorim Correa, M. V. S. C. Moreira, J. M. da Silva Saraiva, E. V. Mancuzo, L. C. dos Santos Silva, and J. R. Lambertucci, “Treatment of schistosomiasis-associated pulmonary hypertension,” Jornal Brasileiro de Pneumologia, vol. 37, no. 2, pp. 272–276, 2011. View at Publisher · View at Google Scholar · View at Scopus
  177. United States Centers for Disease Control and Prevention, “Echinococcosis—biology,” http://www.cdc.gov/parasites/echinococcosis/biology.html.
  178. B. Gottstein and J. Reichen, “Hydatid lung disease (echinococcosis/hydatidosis),” Clinics in Chest Medicine, vol. 23, no. 2, pp. 397–408, 2002. View at Publisher · View at Google Scholar · View at Scopus
  179. A. Kuzucu, “Parasitic diseases of the respiratory tract,” Current Opinion in Pulmonary Medicine, vol. 12, no. 3, pp. 212–221, 2006. View at Publisher · View at Google Scholar · View at Scopus
  180. R. A. Fanne, M. Khamaisi, D. Mevorach et al., “Spontaneous rupture of lung echinococcal cyst causing anaphylactic shock and respiratory distress syndrome,” Thorax, vol. 61, no. 6, p. 550, 2006. View at Publisher · View at Google Scholar · View at Scopus
  181. D. M. Savani and O. P. Sharma, “Eosinophilic lung disease in the tropics,” Clinics in Chest Medicine, vol. 23, no. 2, pp. 377–396, 2002. View at Publisher · View at Google Scholar · View at Scopus
  182. A. Ito, Y. Sako, H. Yamasaki et al., “Development of Em18-immunoblot and Em18-ELISA for specific diagnosis of alveolar echinococcosis,” Acta Tropica, vol. 85, no. 2, pp. 173–182, 2003. View at Publisher · View at Google Scholar · View at Scopus
  183. S. J. Santivañez, P. Arias, M. Portocarrero et al., “Serological diagnosis of lung cystic hydatid disease using the synthetic p176 peptide,” Clinical and Vaccine Immunology, vol. 19, no. 6, pp. 944–947, 2012. View at Publisher · View at Google Scholar · View at Scopus
  184. M. Gencer and E. Ceylan, “Pulmonary echinococcosis with multiple nodules mimicking metastatic lung tumor in chest radiography,” Respiration, vol. 75, no. 3, p. 345, 2008. View at Publisher · View at Google Scholar · View at Scopus
  185. T. Asanuma, T. Kawahara, O. Inanami et al., “Magnetic resonance imaging of alveolar echinococcosis experimentally induced in the rat lung,” Journal of Veterinary Medical Science, vol. 68, no. 1, pp. 15–20, 2006. View at Publisher · View at Google Scholar · View at Scopus
  186. E. Cakir, S. E. Ozaydin, E. Tasci, and R. Baran, “Unusual presentation of hydatid cyst: diagnosis with bronchoscopy,” Journal of Infection in Developing Countries, vol. 4, no. 5, pp. 352–354, 2010. View at Google Scholar · View at Scopus
  187. B. Gottstein and J. Reichen, “Hydatid lung disease,” in Lung Biology in Health and Disease: tropical Lung Disease, O. P. Sharma, Ed., pp. 327–350, Taylor and Francis Group, New York, NY, USA, 2nd edition, 2006. View at Google Scholar
  188. S. Kavukcu, D. Kilic, A. O. Tokat et al., “Parenchyma-preserving surgery in the management of pulmonary hydatid cysts,” Journal of Investigative Surgery, vol. 19, no. 1, pp. 61–68, 2006. View at Publisher · View at Google Scholar · View at Scopus
  189. S. I. Dincer, A. Demir, A. Sayar, M. Z. Gunluoglu, H. V. Kara, and A. Gurses, “Surgical treatment of pulmonary hydatid disease: a comparison of children and adults,” Journal of Pediatric Surgery, vol. 41, no. 7, pp. 1230–1236, 2006. View at Publisher · View at Google Scholar · View at Scopus
  190. E. Pozio, G. la Rosa, K. D. Murrell, and J. R. Lichtenfels, “Taxonomic revision of the genus Trichinella,” Journal of Parasitology, vol. 78, no. 4, pp. 654–659, 1992. View at Google Scholar · View at Scopus
  191. D. D. Despommier, “How does Trichinella spiralis make itself at home?” Parasitology Today, vol. 14, no. 8, pp. 318–323, 1998. View at Publisher · View at Google Scholar · View at Scopus
  192. D. Khemasuwan, C. F. Farver, and A. C. Mehta, “Parasites of the air passages,” Chest, vol. 145, no. 4, pp. 883–895, 2014. View at Google Scholar
  193. F. Bruschi and K. D. Murrell, “New aspects of human trichinellosis: the impact of new Trichinella species,” Postgraduate Medical Journal, vol. 78, no. 915, pp. 15–22, 2002. View at Publisher · View at Google Scholar · View at Scopus
  194. F. S. Pu, “X-ray manifestations of trichinosis on chest radiograph (analysis of 15 cases),” Chinese Journal of Radiology, vol. 23, no. 1, pp. 21–22, 1989. View at Google Scholar · View at Scopus
  195. F. Bruschi and K. Murrell, “Trichinellosis,” in Tropical Infectious Diseases: Principles, Pathogens and Practice, Volume II, R. L. Guerrant, D. H. Walker, and P. F. Weller, Eds., pp. 917–925, Churchill Livingstone (Elsevier Science Health Science Division), Philadelphia, Pa, USA, 1999. View at Google Scholar
  196. E. Engvall and I. Ljungstrom, “Detection of human antibodies to Trichinella spiralis by enzyme linked immunosorbent assay, ELISA,” Acta Pathologica, Microbiologica, et Immunologica Scandinavica, vol. 83, no. 3, pp. 231–237, 1975. View at Google Scholar · View at Scopus
  197. D. D. Colwell, F. Dantas-Torres, and D. Otranto, “Vector-borne parasitic zoonoses: emerging scenarios and new perspectives,” Veterinary Parasitology, vol. 182, no. 1, pp. 14–21, 2011. View at Publisher · View at Google Scholar · View at Scopus
  198. L. Polley, “Navigating parasite webs and parasite flow: emerging and re-emerging parasitic zoonoses of wildlife origin,” International Journal for Parasitology, vol. 35, no. 11-12, pp. 1279–1294, 2005. View at Publisher · View at Google Scholar · View at Scopus
  199. R. Kuchta, J. Brabec, P. Kubáčková, and T. Scholz, “Tapeworm Diphyllobothrium dendriticum (Cestoda) emerging human parasites?” PLoS Neglected Tropical Diseases, vol. 7, no. 12, Article ID e2535. View at Publisher · View at Google Scholar
  200. H. Hakimi, S. Kawai, and S. Kawazu, “Molecular epidemiology of the emerging human malaria parasite, ‘Plasmodium knowlesi’,” Tropical Parasitology, vol. 4, no. 1, pp. 20–24, 2014. View at Google Scholar